We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+7.55%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$39.9B
AUM Growth
+$3.39B
Cap. Flow
+$1.89B
Cap. Flow %
4.72%
Top 10 Hldgs %
7.79%
Holding
3,456
New
750
Increased
762
Reduced
684
Closed
884

Top Buys

Rank Stock Value
1
CARR icon
Carrier Global
CARR
+$293M
2
HON icon
Honeywell
HON
+$209M
3
NSC icon
Norfolk Southern
NSC
+$200M
4
WMT icon
Walmart Inc
WMT
+$199M
5
CMCSA icon
Comcast
CMCSA
+$182M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$286M
2
TJX icon
TJX Companies
TJX
+$198M
3
ASML icon
ASML
ASML
+$187M
4
ADBE icon
Adobe
ADBE
+$181M
5
INTU icon
Intuit
INTU
+$180M

Sector Composition

Rank Sector Weight
1 Industrials 11.39%
2 Technology 10.6%
3 Consumer Discretionary 10.18%
4 Financials 9.8%
5 Healthcare 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNNE icon
2701
Cannae Holdings
CNNE
$651M
-14,297
Closed -$295K
CNX icon
2702
PUT
CNX Resources
CNX
$5.29B
-400,000
Closed -$6.74M
COLL icon
2703
Collegium Pharmaceutical
COLL
$834M
-167,816
Closed -$3.89M
COOK icon
2704
Traeger
COOK
$172M
-244
Closed -$34.4K
COUR icon
2705
Coursera
COUR
$1.48B
-15,357
Closed -$182K
CPRI icon
2706
Capri Holdings
CPRI
$1.77B
-104,307
Closed -$5.98M
CRBG icon
2707
Corebridge Financial
CRBG
$15.1B
-2,015,286
Closed -$40.4M
CRI icon
2708
Carter's
CRI
$1.43B
-225,671
Closed -$16.8M
CRK icon
2709
Comstock Resources
CRK
$4.09B
-691
Closed -$9.47K
CRNX icon
2710
Crinetics Pharmaceuticals
CRNX
$8.96B
-744
Closed -$13.6K
CROX icon
2711
Crocs
CROX
$6.26B
-452,491
Closed -$54.7M
CRSP icon
2712
CRISPR Therapeutics
CRSP
$5.22B
-64,580
Closed -$2.63M
CRUS icon
2713
Cirrus Logic
CRUS
$6.11B
-1,457
Closed -$109K
CSGS
2714
DELISTED
CSG Systems International
CSGS
-24,481
Closed -$1.4M
CSL icon
2715
Carlisle Companies
CSL
$15.2B
-127,694
Closed -$30.1M
CTMX icon
2716
CytomX Therapeutics
CTMX
$760M
-34,800
Closed -$55.7K
CTO
2717
CTO Realty Growth
CTO
$819M
-238,503
Closed -$4.36M
CTS icon
2718
CTS Corp
CTS
$1.82B
-5,598
Closed -$221K
CTSH icon
2719
PUT
Cognizant
CTSH
$26.2B
-7,600
Closed -$435K
CTVA icon
2720
Corteva
CTVA
$50.4B
-420,940
Closed -$24.7M
CUZ icon
2721
Cousins Properties
CUZ
$4.85B
-9,053
Closed -$229K
CVBF icon
2722
CVB Financial
CVBF
$4.05B
-9,101
Closed -$234K
CVS icon
2723
CALL
CVS Health
CVS
$121B
-10,000
Closed -$932K
CVX icon
2724
CALL
Chevron
CVX
$386B
-45,000
Closed -$8.08M
CXW icon
2725
CoreCivic
CXW
$3.32B
-1,562
Closed -$18.1K

Similar funds

Balyasny Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, Balyasny Asset Management held 3,456 positions worth $39.9B, up 9.3% from $36.5B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.

Balyasny Asset Management deployed $1.89B of net new capital in Q1 2023, opening 750 new positions and adding to 762 existing holdings. Its largest new stake was Honeywell: 1,110,808 shares worth $200M.

By sector, the portfolio is most concentrated in Industrials at 11% of assets, up from 11% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $286M trimmed.

  • Balyasny Asset Management's largest Q1 2023 buy was Honeywell: 1,110,808 shares worth $200M.
  • Balyasny Asset Management added most to Carrier Global in Q1 2023, an estimated $293M increase.
  • Balyasny Asset Management's biggest Q1 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $286M.
  • Balyasny Asset Management fully exited STORE Capital Corporation in Q1 2023, selling an estimated $144M.
  • Balyasny Asset Management's ten largest holdings make up 7.8% of its $39.9B portfolio in Q1 2023.
  • Balyasny Asset Management opened 750 new positions and closed 884 in Q1 2023.
  • Balyasny Asset Management's portfolio value rose 9.3% quarter-over-quarter to $39.9B.

Based on Balyasny Asset Management's 13F filing for Q1 2023, filed 15 May 2023.